AXLA
NASDAQAxcella Health Inc.
Latest news
25 items- SECSEC Form 25-NSE filed by Axcella Health Inc.25-NSE - Axcella Health Inc. (0001633070) (Subject)
- SECAxcella Health Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Axcella Health Inc. (0001633070) (Filer)
- SECAxcella Health Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets8-K - Axcella Health Inc. (0001633070) (Filer)
- SECAxcella Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Axcella Health Inc. (0001633070) (Filer)
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Inspire Veterinary (NASDAQ:IVP) shares moved upwards by 26.6% to $0.71 during Thursday's after-market session. The market value of their outstanding shares is at $6.3 million. Telesis Bio (NASDAQ:TBIO) shares moved upwards by 16.57% to $0.47. The market value of their outstanding shares is at $13.9 million. Femasys (NASDAQ:FEMY) shares increased by 13.81% to $1.04. The market value of their outstanding shares is at $22.5 million. Assembly Biosciences (NASDAQ:ASMB) stock moved upwards by 10.14% to $0.71. The market value of their outstanding shares is at $46.8 million. MyMD Pharmaceuticals (NASDAQ:MYMD) stock increased by 9.82% to $0.32. The market value of their outstanding shar
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Telesis Bio (NASDAQ:TBIO) shares increased by 32.5% to $0.53 during Wednesday's after-market session. The company's market cap stands at $15.8 million. Femasys (NASDAQ:FEMY) shares rose 19.28% to $1.09. The market value of their outstanding shares is at $23.5 million. Axcella Health (NASDAQ:AXLA) shares rose 13.1% to $5.18. The company's market cap stands at $15.2 million. Assembly Biosciences (NASDAQ:ASMB) stock increased by 12.96% to $0.73. The market value of their outstanding shares is at $48.0 million. MyMD Pharmaceuticals (NASDAQ:MYMD) stock moved upwards by 9.96% to $0.32. The market value of their outstanding shares is at $14.3 million. Eiger BioPharmaceuticals (NASDAQ:
- SECAxcella Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Axcella Health Inc. (0001633070) (Filer)
- SECSEC Form S-8 POS filed by Axcella Health Inc.S-8 POS - Axcella Health Inc. (0001633070) (Filer)
- SECSEC Form S-8 POS filed by Axcella Health Inc.S-8 POS - Axcella Health Inc. (0001633070) (Filer)
- SECSEC Form DEF 14A filed by Axcella Health Inc.DEF 14A - Axcella Health Inc. (0001633070) (Filer)
- SECAxcella Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Axcella Health Inc. (0001633070) (Filer)
- SECSEC Form PRE 14A filed by Axcella Health Inc.PRE 14A - Axcella Health Inc. (0001633070) (Filer)
- SECAxcella Health Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - Axcella Health Inc. (0001633070) (Filer)
- SECAxcella Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events8-K - Axcella Health Inc. (0001633070) (Filer)
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers Bionomics (NASDAQ:BNOX) stock increased by 261.4% to $3.56 during Thursday's regular session. As of 13:30 EST, Bionomics's stock is trading at a volume of 94.1 million, which is 38818.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.0 million. Baudax Bio (NASDAQ:BXRX) stock rose 74.26% to $0.52. Trading volume for Baudax Bio's stock is 145.1 million as of 13:30 EST. This is 6961.2% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million. Femasys (NASDAQ:FEMY) shares increased by 41.45% to $1.57. As of 13:30 EST, Femasys's stock is trading at a volume of 27.4 million, whic
- NEWSWhy CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers Bionomics Limited (NASDAQ:BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Baudax Bio, Inc. (NASDAQ:BXRX) gained 109% to $0.6287 after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors. Chico's FAS, Inc. (NYSE:CHS) shares climbed 61.7% to $7.45 following the announcement of its acquisition by Sycamore Partners for $1 billion. Aditxt, Inc. (NASDAQ:ADTX) gained 57% to $20.47. Axcella Health Inc. (NASDAQ:AXLA) rose 31.3% to $9.08.
- NEWSAxcella Health Shares Resumed Trade
- NEWSAxcella Health Shares Halted On Circuit Breaker To The Upside, Stock Now Up 46.9%
- NEWSAxcella Health Shares Resume Trading
- NEWSAxcella Health Shares Halted On Circuit Breaker To The Upside, Stock Now Up 38.2%
- NEWSAxcella Health Shares Resume Trade
- NEWSAxcella Health Shares Halted On Circuit Breaker To The Upside, Stock Now Up 33.1%
- NEWSWhy Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after the close. Shareholders voted to approve a reverse split on Aug. 21. After the closing bell on Tuesday, ShiftPixy said the one-for-twenty-four reverse split will take effect on Sept. 30. SciSparc Ltd. (NASDAQ:SPRC) gained 120.9% to $0.3450. The company reported its previously announced 1-for-26 reverse share split is expected to be implemented after market close today. Rite Aid Corporation (NYSE:RAD) climbed 44% to $0.6175. Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed
- NEWSWhy Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketGainers ShiftPixy, Inc. (NASDAQ:PIXY) shares rose 69.9% to $0.7391 in pre-market trading. The company announced the effective date for its reverse stock split after the close. Shareholders voted to approve a reverse split on Aug. 21. After the closing bell on Tuesday, ShiftPixy said the one-for-twenty-four reverse split will take effect on Sept. 30. MSP Recovery, Inc. (NASDAQ:LIFW) shares rose 41.7% to $0.2155 in pre-market trading after falling around 25% on Tuesday. Cardiff Oncology, Inc. (NASDAQ:CRDF) shares gained 35.8% to $2.20 in pre-market trading after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent activity from onvanse
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers TransCode Therapeutics (NASDAQ:RNAZ) shares rose 219.3% to $2.12 during Monday's regular session. TransCode Therapeutics's stock is trading at a volume of 72.3 million shares as of 13:30 EST. This is 12088.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.2 million. Vaccitech (NASDAQ:VACC) shares increased by 82.73% to $3.07. Trading volume for Vaccitech's stock is 18.2 million as of 13:30 EST. This is 135511.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.2 million. Biophytis (NASDAQ:BPTS) shares moved upwards by 71.57% to $1.51. As of 13:30 EST, this se
AXLA FAQ
7 questionsWhat does Axcella Health Inc. do?
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. It also develops AXA4010, a hematology product candidate; and AXA2678, a muscle product candidate. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in...Where does AXLA stock trade?
Axcella Health Inc. (AXLA) is listed on NASDAQ.What sector and industry is AXLA in?
Axcella Health Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Axcella Health Inc. go public?
Axcella Health Inc. (AXLA) completed its IPO in 2019.What are analysts saying about AXLA?
Axcella Health Inc. has had 5 recent analyst actions on file. The most recent action was from Chardan Capital: Buy with a $1200.00 price target on 2021-11-16. Recent price targets range from $500.00 to $1400.00.What companies are similar to AXLA?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare AXLA side-by-side with any of them on Quantisnow.How can I track AXLA on Quantisnow?
Quantisnow aggregates Axcella Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AXLA to receive live email and push alerts on every new disclosure.